Yatırımcı.AI

LILAK vs ECILC Comparison

Price, market cap, valuation, profitability and leverage metrics of LILAK and ECILC side by side.

LILAKECILC
StockFund

If You Had Invested TRY 10,000

Metric Comparison

LILAK vs ECILC Comparison
MetricLILAKECILCSector median
Last price (TL)24.0463.9516.30
Daily change−4.60%−6.64%−5.32%
Market capTRY 14.2BTRY 43.8BTRY 2.7B
P/E13.40—6.82
P/B0.800.681.24
Dividend yield4.33%2.04%2.52%
Return on equity6.56%−3.08%−1.04%
Free float16.96%22.02%34.99%
Ratios are calculated from the latest published financial statements.

Popular Comparisons

Related Pages

About the LILAK vs ECILC Comparison

Price, market cap, valuation multiples, profitability and leverage of LILAK (Lila Kağıt) and ECILC (Eczacıbaşı İlaç) side by side as of Sep 28, 2026, 15:02. Of the 16 metrics compared, LILAK leads in 11 and ECILC leads in 5.

Highlights: Daily change: LILAK leads (−4.60% vs −6.64%). Market cap: ECILC leads (TRY 43.8B vs TRY 14.2B). P/B: ECILC leads (0.68 vs 0.80). EV/EBITDA: LILAK leads (4.16 vs 165.19). EV/Sales: LILAK leads (1.30 vs 9.35). Dividend yield: LILAK leads (4.33% vs 2.04%). Gross margin: ECILC leads (37.83% vs 30.03%). EBITDA margin (annual): LILAK leads (24.04% vs 11.49%).

Frequently Asked Questions

By P/E, Tie is cheaper (13.40 vs —); by P/B, ECILC trades at the lower multiple (0.80 vs 0.68).

Annual net margin is 8.96% for LILAK and −20.86% for ECILC; return on equity is 6.56% for LILAK and −3.08% for ECILC.

The leverage ratio is 25.49 for LILAK and 18.92 for ECILC; net debt/EBITDA is −1.83 for LILAK and 1.37 for ECILC. Lower values mean less leverage.

Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.